Ovoca Bio Plc
Biopharma developing a novel therapy for premenopausal women with low sexual desire (HSDD).
OVXA | IR
Overview
Corporate Details
- ISIN(s):
- IE0006649010 (+1 more)
- LEI:
- 213800ST2AK5XQ1O5207
- Country:
- Ireland
- Address:
- 17 PEMBROKE STREET UPPER, D02 AT22 DUBLIN
- Website:
- https://ovocabio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Ovoca Bio Plc is a clinical-stage biopharmaceutical company focused on developing novel treatments for women's health. The company's lead product candidate is Orenetide, a medicinal therapy for premenopausal women with hypoactive sexual desire disorder (HSDD), a condition with significant unmet medical need. Ovoca Bio is advancing Orenetide through clinical development and regulatory approval processes in the US, Europe, and other major global markets. The company's strategy involves leveraging its protective patent portfolio and seeking commercialization through licensing agreements and collaborations with pharmaceutical partners.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-30 14:09 |
Report Publication Announcement
Replacement Half Year Report
|
English | 10.8 KB | ||
| 2025-06-05 08:00 |
Delisting Announcement
Delisting from Euronext Growth Exchange
|
English | 9.0 KB | ||
| 2025-03-03 15:00 |
Board/Management Information
Management Changes
|
English | 8.0 KB | ||
| 2024-12-18 19:00 |
Post-Annual General Meeting Information
Result of AGM
|
English | 7.1 KB | ||
| 2024-11-18 08:00 |
Pre-Annual General Meeting Information
Notice of AGM
|
English | 7.0 KB | ||
| 2024-10-11 18:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 6.8 KB | ||
| 2024-10-09 18:45 |
Transaction in Own Shares
Sale of Treasury Shares
|
English | 6.0 KB | ||
| 2024-09-25 08:00 |
Report Publication Announcement
Half-year Report
|
English | 7.6 KB | ||
| 2024-09-02 15:30 |
Related Party Transaction
Consultancy Agreement
|
English | 8.7 KB | ||
| 2024-07-15 08:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 27.4 KB | ||
| 2024-07-15 08:00 |
Board/Management Information
Directorate Change
|
English | 8.8 KB | ||
| 2024-06-28 08:00 |
Report Publication Announcement
Annual Financial Report
|
English | 14.5 KB | ||
| 2024-06-20 00:00 |
Annual Report
|
English | 1.2 MB | ||
| 2024-01-23 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 7.9 KB | ||
| 2023-12-01 13:00 |
Post-Annual General Meeting Information
Result of AGM
|
English | 7.8 KB |
Automate Your Workflow. Get a real-time feed of all Ovoca Bio Plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ovoca Bio Plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ovoca Bio Plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
